SPOTLIGHT -
Check out our live coverage of this year's MGMA conference.
Oral Povorcitinib Significantly Improves Total, Facial Vitiligo in 24 Week Trial
Kirsten Johansen, MD: Improving the Quality of Life for CKD Patients With Anemia
Oral Roflumilast Effective, Safe in Treating Plaque Psoriasis Over 24 Weeks
John J. Miller, MD: A New Era For Psychiatric Medications
Orismilast Tablets Significantly Clear Psoriasis Skin
Phase 3 Trial Data on Bimekizumab for Patients with Hidradenitis Suppurativa